Wolf MK - Search Results

1

Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group study.

Marshall ME, Wolf MK, Crawford ED, Taylor S, Blumenstein B, Flanigan R, Meyers FJ, Hynes HE, Barlogie B, Eisenberger M. Marshall ME, et al. Among authors: wolf mk. Invest New Drugs. 1993 May-Aug;11(2-3):207-9. doi: 10.1007/BF00874157. Invest New Drugs. 1993. PMID: 8262733 Clinical Trial.

2

Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group Study.

Marshall ME, Wolf MK, Crawford ED, Weiss GR, Ahmann F, Meyers FJ, Blumenstein B, Eisenberger M, Einstein AB. Marshall ME, et al. Among authors: wolf mk. Am J Clin Oncol. 1995 Oct;18(5):400-2. doi: 10.1097/00000421-199510000-00008. Am J Clin Oncol. 1995. PMID: 7572756 Clinical Trial.

3

Phase II evaluation of didemnin B in hormonally refractory metastatic prostate cancer. A Southwest Oncology Group study.

Williamson SK, Wolf MK, Eisenberger MA, O'Rourke M, Brannon W, Crawford ED. Williamson SK, et al. Among authors: wolf mk. Invest New Drugs. 1995;13(2):167-70. doi: 10.1007/BF00872867. Invest New Drugs. 1995. PMID: 8617581 Clinical Trial.

4

Phase II evaluation of merbarone in renal cell carcinoma.

Flanigan RC, Saiers JH, Wolf M, Kraut EH, Smith AY, Blumenstein B, Crawford ED. Flanigan RC, et al. Invest New Drugs. 1994;12(2):147-9. doi: 10.1007/BF00874446. Invest New Drugs. 1994. PMID: 7860233 Clinical Trial.

5

Evaluation of low dose alpha-interferon (Roferon-A) in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.

Marshall ME, Wolf M, Crawford ED, Thompson IM, Flanigan R, Balcerzak SP, Meyers FJ. Marshall ME, et al. Cancer Biother. 1995 Fall;10(3):205-9. doi: 10.1089/cbr.1995.10.205. Cancer Biother. 1995. PMID: 8547959 Clinical Trial.

6

Phase II evaluation of piroxantrone in renal cell carcinoma. A Southwest Oncology Group Study.

Allen A, Wolf M, Crawford ED, Davis MP, Natale RB, Barnett ML. Allen A, et al. Invest New Drugs. 1992 Jul;10(2):129-32. doi: 10.1007/BF00873131. Invest New Drugs. 1992. PMID: 1500267 Free article. Clinical Trial.

7

Phase II evaluation of amonafide in renal cell carcinoma. A Southwest Oncology Group study.

Higano CS, Goodman P, Craig JB, Kish JA, Rivkin SE, Wolf M, Crawford ED. Higano CS, et al. Invest New Drugs. 1991 Nov;9(4):361-3. doi: 10.1007/BF00183582. Invest New Drugs. 1991. PMID: 1804814 Clinical Trial.

8

A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.

Whitehead RP, Wolf MK, Solanki DL, Hemstreet GP 3rd, Benedetto P, Richman SP, Flanigan RC, Crawford ED. Whitehead RP, et al. Among authors: wolf mk. J Immunother Emphasis Tumor Immunol. 1995 Aug;18(2):104-14. doi: 10.1097/00002371-199508000-00004. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8574465 Clinical Trial.

9

Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group study.

Williamson SK, Wolf MK, Eisenberger MA, O'Rourke MA, Brannon W, Crawford ED. Williamson SK, et al. Among authors: wolf mk. Am J Clin Oncol. 1996 Aug;19(4):368-70. doi: 10.1097/00000421-199608000-00009. Am J Clin Oncol. 1996. PMID: 8677906 Clinical Trial.

10

Alternating combination chemotherapy in patients with extragonadal germ cell tumors. A Southwest Oncology Group study.

Bukowski RM, Wolf M, Kulander BG, Montie J, Crawford ED, Blumenstein B. Bukowski RM, et al. Cancer. 1993 Apr 15;71(8):2631-8. doi: 10.1002/1097-0142(19930415)71:8<2631::aid-cncr2820710831>3.0.co;2-g. Cancer. 1993. PMID: 7680950 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters